BD is rolling out a new monitoring platform equipped with artificial intelligence-powered programs that aim to predict ...

Biolinq has raised $100 million in venture capital financing to help complete the development of its wearable glucose ...

Harvard University is suing President Trump's administration over its threats to freeze billions in research funding. | Harvard University is suing President Trump's administration over its threats to ...

Roche’s drug production operations are set to benefit from the company’s updated U.S. strategy, including with “expanded and ...

The mandate overrules Section 4.1.2 “Civil Rights Protections” of the NIH Grants Policy Statement, which includes the Civil ...

The National Institutes of Health (NIH) is halting new grant and contract payments to several universities, a move the agency ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

It’s been five years since the U.K.’s breakup with the European Union, and the impacts of extra red tape and rising costs ...

That means the future of Roivant is tied to the success, or otherwise, of Immunovant’s attempts to break into the FcRn market ...

Tempest Therapeutics is hunkering down to weather the storm that has engulfed its operations. | Tempest Therapeutics is ...

Chico, Vice President and Global Head of Oncology Therapeutic Expertise at Fortrea, shares how scientific advances, AI tools and flexible CRO models are accelerating oncology trials and improving ...

We hoped industry layoffs would relent in 2024. That's not what happened. Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data. So, here we are ...